JianguoTaoMD

PubMed

• 2 citations
  Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.
  Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, Krysta Mila Coyle, Laura K Hilton, Evangelia Chavdoula, Parvathi Ranganathan, Neeraj Jain, Walter Hanel, Philip ...> ;Leukemia. 2023 Oct 1
• MCL1 as a therapeutic vulnerability in Burkitt lymphoma.
  Ren Yuan, Michelle Y Wang, Chengfeng Bi, Xiaohong Zhao, Jianguo Tao> ;Leukemia. 2023 Apr 1
• 2 citations
  Frontline treatment approaches in-aberrant mantle cell lymphoma.
  Franco Castillo-Tokumori, Junmin Whiting, David Boulware, Jose Sandoval-Sus, Todd C Knepper, Mohammad Hussaini, Jianguo Tao, Julio C Chavez, Leidy Isenalumhe, Sameh Ga...> ;Leukemia & Lymphoma. 2023 Jan 1
• 4 citations
  Bone-Targeted Bortezomib Inhibits Bortezomib-Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in Bone.
  Jianguo Tao, Venkat Srinivasan, Xiangjiao Yi, Yingchun Zhao, Hengwei Zhang, Xi Lin, Xichao Zhou, Brendan F Boyce, Peter W Villalta, Frank H Ebetino, Koc Kan Ho, Robert...> ;Journal of Bone and Mineral Research. 2022 Apr 1
• 3 citations
  Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas.
  Jing Gao, Michelle Wang, Yuan Ren, Tint Lwin, Tao Li, J. Yan, Eduardo M. Sotomayor, Derek R Duckett, Bijal D. Shah, Kenneth H. Shain, Xiaohong Zhao, Jianguo Tao> ;Haematologica. 2021 Jun 24
• 20 citations
  Bisphosphonates for delivering drugs to bone
  Shuting Sun, Jianguo Tao, Parish P. Sedghizadeh, Philip T. Cherian, Adam Junka, Esmat Sodagar, Lianping Xing, Robert K. Boeckman, Venkatesan Srinivasan, Zhenqiang Yao,...> ;British Journal of Pharmacology. 2021 May 1
• 7 citations
  HDAC11 regulates expression of C/EBPβ and immunosuppressive molecules in myeloid-derived suppressor cells.
  Jie Chen, Fengdong Cheng, Eva Sahakian, John Powers, Zi Wang, Jianguo Tao, Edward Seto, Javier Pinilla-Ibarz, Eduardo M. Sotomayor> ;Journal of Leukocyte Biology. 2021 May 1
• 9 citations
  Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
  Xiaohong Zhao, Michelle Wang, Huijuan Jiang, Tint Lwin, Paul M.C. Park, Jing Gao, Mark B. Meads, Yuan Ren, Tao Li, Jiao Sun, Naima Ahmed Fahmi, Satishkumar Singh, Lali...> ;Cell Reports. 2021 Mar 16
• 4 citations
  MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
  Michelle Wang, Tao Li, Yuan Ren, Bijal D. Shah, Tint Lwin, Jing Gao, Kenneth H. Shain, Wei Zhang, Xiaohong Zhao, Jianguo Tao> ;Blood Cancer Journal. 2021 Jan 14
• 28 citations
  Targeting anti-cancer agents to bone using bisphosphonates.
  Lianping Xing, Frank H. Ebetino, Robert K. Boeckman, Venkat Srinivasan, Jianguo Tao, Tomi K. Sawyer, Jinbo Li, Zhenqiang Yao, Brendan F. Boyce> ;Bone. 2020 Jun 23
• Erratum: Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in ma...
  Rekha Rao, Srilatha Nalluri, Warren Fiskus, Andrew Savoie, Kathleen M. Buckley, Kyungsoo Ha, Ramesh Balusu, Atul Joshi, Veena Coothankandaswamy, Jianguo Tao, Eduardo M...> ;Clinical Cancer Research. 2020 Mar 15
• 20 citations
  Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice.
  Hua Wang, Hengwei Zhang, Venkat Srinivasan, Jianguo Tao, Wen Sun, Xi Lin, Tao Wu, Brendan F. Boyce, Frank H. Ebetino, Robert K. Boeckman, Lianping Xing> ;Journal of Bone and Mineral Research. 2020 Feb 1
• 49 citations
  BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
  Xiaohong Zhao, Yuan Ren, Matthew A. Lawlor, Bijal D. Shah, Paul M.C. Park, Tint Lwin, Xuefeng Wang, Kenian Liu, Michelle Wang, Jing Gao, Tao Li, Mousheng Xu, Ariosto S...> ;Cancer Cell. 2019 May 13
• 12 citations
  Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma.
  Huijuan Jiang, Tint Lwin, Xiaohong Zhao, Yuan Ren, Grace T Li, Lynn C. Moscinski, Bijal D. Shah, Jianguo Tao> ;British Journal of Haematology. 2019 Jan 1
• 60 citations
  PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
  Yuan Ren, Chengfeng Bi, Xiaohong Zhao, Tint Lwin, Cheng Wang, Ji Yuan, Ariosto S. Silva, Bijal D. Shah, Bin Fang, Tao Li, John M. Koomen, Huijuan Jiang, Julio C. Chave...> ;The Journal of Clinical Investigation. 2018 Dec 3
• 23 citations
  Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice
  Hua Wang, Lifeng Xiao, Jianguo Tao, Venkat Srinivasan, Brendan F. Boyce, Frank H. Ebetino, Babatunde O. Oyajobi, Robert K. Boeckman, Lianping Xing> ;Pharmaceutics. 2018 Sep 10
• 12 citations
  Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All
  Bijal D. Shah, Xiaohong Zhao, Ariosto S. Silva, Kenneth H. Shain, Jianguo Tao> ;Trends in Cancer. 2018 Mar 1
• 2 citations
  BRD4: epigenetic origin and target of CTCL.
  Xiaohong Zhao, Jianguo Tao> ;Blood. 2018 Feb 15
• 110 citations
  Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
  Xiaohong Zhao, Tint Lwin, Ariosto S. Silva, Bijal D. Shah, J Tao, Bin Fang, Liang Zhang, Kai Fu, Chengfeng Bi, Jiannong Li, Huijuan Jiang, Mark B. Meads, Timothy Jacob...> ;Nature Communications. 2017 Apr 18
• 78 citations
  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
  Kenneth H. Shain, William S. Dalton, J Tao> ;Oncogene. 2015 Sep 3
• 35 citations
  Polycomb genes, miRNA, and their deregulation in B-cell malignancies.
  Gang Greg Wang, Kyle D. Konze, Jianguo Tao> ;Blood. 2015 Feb 19
• 4 citations
  Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation
  J Tao, Xiaohui Zhang, Jeffrey E. Lancet, John M. Bennett, Li Cai, Peter Papenhausen, Lynn C. Moscinski, Ling Zhang> ;Cancer Genetics. 2014 Oct 1
• 76 citations
  A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
  Fengdong Cheng, Maritza Lienlaf, Hongwei Wang, Patricio Perez-Villarroel, Calvin Lee, Karrune Woan, Jennifer Rock-Klotz, Eva Sahakian, David M. Woods, Javier Pinilla-I...> ;Journal of Immunology. 2014 Sep 15
• 20 citations
  The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies
  Kenneth H. Shain, J Tao> ;Oncogene. 2014 Aug 7
• 132 citations
  Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival
  Chih-Hang Anthony Tang, Sujeewa Ranatunga, Crystina L. Kriss, Christopher L. Cubitt, Jianguo Tao, Javier Pinilla-Ibarz, Juan R. Del Valle, Chih-Chi Andrew Hu> ;The Journal of Clinical Investigation. 2014 Jun 2
• Join now to see all

Lectures

• Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018